Cargando…
TDP-43 Pathology and Prionic Behavior in Human Cellular Models of Alzheimer’s Disease Patients
Alzheimer’s disease (AD) is a neurodegenerative disorder for which there is currently no effective treatment. Despite advances in the molecular pathology of the characteristic histopathological markers of the disease (tau protein and β-amyloid), their translation to the clinic has not provided the e...
Autores principales: | Cuevas, Eva P., Rodríguez-Fernández, Alberto, Palomo, Valle, Martínez, Ana, Martín-Requero, Ángeles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962248/ https://www.ncbi.nlm.nih.gov/pubmed/35203594 http://dx.doi.org/10.3390/biomedicines10020385 |
Ejemplares similares
-
TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients
por: Martinez-Gonzalez, Loreto, et al.
Publicado: (2023) -
TDP-43 Pathology in Alzheimer’s Disease
por: Meneses, Axel, et al.
Publicado: (2021) -
Do We Need Anti-Prionic Compounds to Treat Alzheimer’s Disease?
por: Willbold, Dieter, et al.
Publicado: (2019) -
Progranulin Deficiency Induces Mitochondrial Dysfunction in Frontotemporal Lobar Degeneration with TDP-43 Inclusions
por: Rodríguez-Periñán, Guiomar, et al.
Publicado: (2023) -
Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment
por: Martínez-González, Loreto, et al.
Publicado: (2020)